FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: NASDAQ:CBLI

Sort
E.g., 2013-05-19
E.g., 2013-05-19
Enter a comma separated list of user names.

Cleveland BioLabs, Inc. (NASDAQ:CBLI) previously reported that CBLB502, a drug under development to treat exposure to radiation, has been granted Orphan Drug status by the U.S. Food and Drug Administration (FDA) for prevention of death following a potentially lethal dose of total body irradiation during or after a radiation disaster.

Proteonomix, Inc. (OTC.BB:PROT) is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. Proteonomix reported that Mr. Michael Cohen, Chairman and CEO, is scheduling a multi-city European road trip to create additional awareness of the Proteonomix, Inc. investment opportunity to institutional investors.

ADVERTISE WITH US